Replies to post #7 on Move Inc. (MOVE)

[derkampfer]

It would seem to me once MOVE has FDA approval on their glucose monitoring chip that Apple would like to get their hands on it. Somehow. Not sure if that means MOVE keeps their women-centric Evie ring product line and sells Apple licensing rights to the chip or simply turns the whole company over and makes the Evie ring an Apple product offering, as they did with Beats by Dre and that $3B deal. Not the same since Beats was more about Apple buying the Dre name-culture-brand and in this case an acquisition by Apple of MOVE is for their tech. At which point medical grade glucose monitoring could then be incorporated into the AppleWatch and perhaps iPhone. That’s why we are invested. FDA approval of their glucose monitoring chip is a key event that they are working towards.